The treatment of glucocorticoid-induced osteoporosis

J Steroid Biochem Mol Biol. 2004 Apr;88(4-5):337-49. doi: 10.1016/j.jsbmb.2004.01.003.

Abstract

Glucocorticoid use results in an increase risk for fractures. Over the past 10 years, we have a greater understanding of the epidemiology, pathophysiology, prevention and treatment of glucocorticoid induced osteoporosis. This article reviews these recent findings and selective practice guidelines.

Publication types

  • Review

MeSH terms

  • Calcitonin / therapeutic use
  • Calcium / therapeutic use
  • Diphosphonates / therapeutic use
  • Fluorides / therapeutic use
  • Glucocorticoids / adverse effects*
  • Hormone Replacement Therapy
  • Humans
  • Osteoporosis / chemically induced*
  • Osteoporosis / drug therapy*
  • Osteoporosis / etiology
  • Vitamin D / therapeutic use

Substances

  • Diphosphonates
  • Glucocorticoids
  • Vitamin D
  • Calcitonin
  • Fluorides
  • Calcium